Gilead’s Captisol-enabled Remdesivir Approved for Use in Renally Impaired Patients
Read full release and find prescribing information

Captisol® and Pfizer

Captisol® and Pfizer

Pfizer identified a clinical need for an intravenous formulation of its antifungal compound, voriconazole, which was also available as an oral tablet. Captisol addressed voriconazole's technical challenge of low solubility by achieving a high concentration for an intravenous dosage form. 

See Case Study: Partnering with Big Pharma

Interested In Partnering?

Contact us today and take the first step to a great partnership.

Contact Us